Neuroathletic Training in Adolescent Basketball Players (NCT07584148) | Clinical Trial Compass
CompletedNot Applicable
Neuroathletic Training in Adolescent Basketball Players
Turkey (Türkiye)30 participantsStarted 2025-02-15
Plain-language summary
This randomized controlled study aims to investigate the effects of neuroathletic training on dynamic visual acuity, endurance, balance, and injury risk in adolescent basketball players. Licensed basketball players aged 14-17 years will be randomly assigned to either a neuroathletic training group or a control group. The training group will receive sport-specific progressive neuroathletic exercises in addition to their regular basketball training for one week, while the control group will continue their usual training routine. Before and after the intervention, participants will be assessed for dynamic visual acuity, core muscle endurance, balance, functional movement, pain, and kinesiophobia. The findings of this study may help clarify whether neuroathletic training can improve performance-related outcomes and reduce injury risk in adolescent basketball players.
Who can participate
Age range
14 Years – 17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Aged between 14 and 17 years, Being a professional or amateur basketball player, Participating in sports for at least five hours per week and having engaged in the sport for a minimum of two years, Having no cognitive or motor dysfunction, Providing written informed consent signed by the parents/legal guardians.
Exclusion Criteria:
Reporting a back or lower extremity injury within the previous six months, Having any relevant medical history or current condition that could affect the balance system or perception-action system (e.g., neurological disorders, inner ear disorders, or color blindness), Using medications or substances that could affect balance and visual-motor reaction time performance.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Functional Movement Screen (FMS) total score
Timeframe: Baseline and immediately following the 1-week intervention